Gilead Sciences Q2 2016 Earnings Results

Gilead Sciences presents Q2 2016 earnings results with financial commentary from executive leadership including CEO John Milligan and CFO Robin Washington. The presentation covers antiviral programs, HCV treatment products, and pipeline candidates including oncology and inflammation programs.